PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsGlutamic acid
D-glutamate
D-glutamate is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
No data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name
Status
Last Update
aminosyn iiNew Drug Application2022-05-04
aminosyn-pfNew Drug Application2022-07-21
clinisolANDA2018-06-01
kabivenNew Drug Application2023-08-02
perikabivenNew Drug Application2023-08-07
plenamineANDA2023-04-21
premasol - sulfite-free (amino acid)ANDA2022-08-04
prosolNew Drug Application2020-10-07
trophamineNew Drug Application2023-11-27
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameD-glutamate
INN
Description
D-glutamic acid is an optically active form of glutamic acid having D-configuration. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a D-alpha-amino acid and a glutamic acid. It is a conjugate acid of a D-glutamate(1-). It is an enantiomer of a L-glutamic acid.
Classification
Small molecule
Drug class
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
N[C@H](CCC(=O)O)C(=O)O
Identifiers
PDB
CAS-ID6893-26-1
RxCUI
ChEMBL IDCHEMBL76232
ChEBI ID15966
PubChem CID23327
DrugBankDB02517
UNII ID
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
Black-box warning for: Aminosyn ii
Adverse Events
0 adverse events reported
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use